date
coher
model
emerg
explain
prevent
treat
rapid
respiratori
failur
proxim
caus
death
minor
novel
coronaviru
covid
patient
similarli
fact
remain
true
acut
respiratori
distress
syndrom
ard
first
describ
ashbaugh
sever
acut
respiratori
syndrom
clearli
small
subset
infect
individu
rapidli
progress
often
hour
day
initi
symptom
fever
dyspnea
fullblown
respiratori
failur
requir
mechan
ventil
other
remain
essenti
asymptomat
place
ventil
death
rate
report
percent
percent
depend
age
risk
factor
current
explan
offer
explain
event
cytokin
storm
syndrom
css
howev
model
lack
mani
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
respect
readili
lead
broad
base
hypothesi
test
immedi
current
fda
investig
drug
expand
accesscompassion
use
pathway
use
system
biolog
frame
conduct
comprehens
review
autopsi
work
report
relat
death
review
literatur
concern
hyaluronan
respect
acut
respiratori
distress
syndrom
ard
found
consist
statist
signific
increas
report
lung
weight
autopsi
confirm
victim
histolog
find
hyalin
membran
classic
describ
ard
sar
mer
autopsi
well
significantli
first
report
two
complet
autopsi
english
languag
literatur
observ
lung
weight
victim
posit
nasopharyng
bilater
lung
parenchym
swab
rrtpcr
weigh
approxim
time
normal
adult
lung
weight
lung
describ
autopsi
bag
water
person
commun
sharp
contrast
importantli
obes
man
determin
die
postmortem
examin
nasopharyng
swab
test
posit
neg
lung
parenchym
swab
normal
lung
weight
find
acut
bronchopneumonia
hyalin
membran
believ
may
serv
confirm
uniqu
caus
death
induc
supernorm
outpour
hyaluronan
short
time
interv
confin
space
human
chest
caviti
propos
defin
new
model
induc
hyaluronan
storm
ih
syndrom
comprehens
specif
action
paradigm
frame
address
global
crisi
specif
prevent
death
highrisk
group
modig
elegantli
demonstr
hyaluron
acid
induc
within
minut
alveolar
fluid
lead
dose
depend
reduct
pulmonari
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
oxygen
index
pao
fao
demonstr
increas
alveolar
hyaluron
acid
concentr
ard
patient
compar
control
state
hyaluron
acid
power
water
edema
bind
substanc
bodi
put
forth
humor
biochemicalphysiolog
hypothesi
ard
other
recent
detail
central
role
hyaluron
acid
human
respiratori
diseas
viral
infect
lead
mark
rapid
increas
hyaluron
acid
concentr
mckallip
et
al
report
vitro
anim
model
ard
target
hyaluron
acid
synthesi
might
novel
target
treatment
reduct
induc
lung
injuri
use
eleg
combin
cell
base
murin
studi
show
possibl
profoundli
suppress
product
hyaluronan
inhibit
three
isoenzym
hyaluronan
follow
studi
group
went
show
nontox
molecul
reduc
express
enzym
produc
ha
reduc
level
ha
lung
sebexpos
mice
treatment
led
reduct
sebinduc
lung
permeabl
reduc
cytokin
product
bray
other
demonstr
bleomycininduc
lung
injuri
model
maxim
hyaluronan
content
reach
seven
day
fold
normal
valu
reev
et
al
show
human
lung
fibroblast
hlf
treat
viral
mimet
polyinosinepolycytidyl
acid
tolllik
receptor
agonist
encourag
accumul
hyaluronanrich
extracellular
matrix
ecm
enhanc
monocyt
lymphocyt
bind
shown
activ
mast
cell
innat
immun
cell
particularli
acut
respiratori
infect
respiratori
syncyti
viru
rsv
lead
format
hyaluronanenrich
ecm
emphas
rsv
infect
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
hlf
encourag
inflamm
via
hyaluronandepend
mechan
enhanc
mast
cell
proteas
express
direct
contact
shown
hyaluronan
ecm
variou
degrad
product
vitro
signific
contributor
immunomodulatori
function
ecm
acut
chronic
respiratori
diseas
paul
bollyki
md
phd
nadin
nagi
phd
et
al
research
stanford
extens
review
use
anim
human
studi
term
mechan
action
pharmacokinet
safeti
respect
cancer
autoimmun
research
report
eight
human
studi
date
back
involv
hyaluronan
ca
ncer
conclud
potenti
hymecromon
develop
repurpos
safe
longterm
adjunct
therapi
cancer
treatment
potenti
indic
method
studi
type
systemat
comprehens
review
autopsi
report
scientif
literatur
use
key
search
term
inclus
criteria
studi
autopsi
report
search
result
involv
select
term
autopsi
hyaluronan
hyaluron
acid
ard
exclus
criteria
studi
exclud
lack
correspond
outcom
paramet
research
data
ii
avail
full
text
figur
includ
full
report
origin
data
appli
exclus
base
languag
search
deadlin
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
scopu
electron
databas
deem
suffici
scientif
qualiti
summar
autopsi
find
compar
associ
outcom
relev
studi
collat
result
citat
relat
hyaluronan
ard
find
compil
outcom
statu
report
form
tabl
list
signific
find
statist
analysi
carri
respect
ard
normal
lung
weight
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
identifi
elig
public
remov
duplic
figur
public
exclud
screen
titl
abstract
remain
public
review
fulltext
read
one
public
meet
inclus
criteria
exclud
leav
public
analys
public
consid
suffici
scientif
qualiti
anatom
histolog
find
report
collat
compil
tabl
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
find
report
present
autopsi
report
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
averag
lung
weight
plot
matlab
mathwork
natick
usa
microsoft
excel
microsoft
corpor
redmond
wa
usa
posthoc
analysi
use
tukey
hsd
honestli
signific
differ
indic
group
statist
signific
provid
percent
confid
interv
group
import
note
perform
tukey
hsd
test
requir
student
rang
distribut
due
limit
number
lung
weight
confirm
ih
victim
determin
pvalu
point
howev
clearli
observ
lung
weight
seen
ih
ihsautopsi
believ
indic
signific
differ
one
ih
case
record
combin
lung
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
employ
system
biolog
ather
reductionist
approach
better
r
character
understand
mechan
associ
morbid
mortal
associ
propos
hyperacut
rise
hylauronan
concentr
appreci
neglect
sinc
first
descript
clinic
featur
ard
base
care
autopsi
result
morpholog
spacial
implic
sudden
outpour
hyaluron
acid
sequestr
water
alveolar
environ
fulli
appreci
specif
address
mani
way
insult
respons
insult
character
quantifiedmorpholog
physiolog
molecularli
biochem
genet
exampl
unfortun
focu
current
histor
center
stream
consequ
critic
key
physic
dimens
spacial
aspect
larg
volum
accumul
misplac
water
lung
essenti
lung
parenchyma
direct
consequ
massiv
increas
hyaluronan
rapidli
becom
satur
water
shift
water
demonstr
begin
occur
within
minut
direct
result
varieti
injuri
case
yet
unknown
particularli
lethal
aspect
infect
within
minut
lead
chang
result
acut
respiratori
distress
requir
ventil
within
hour
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
critic
respect
mechan
follow
convent
treatment
posit
pressur
ventil
manner
antiinflammatori
medic
overcom
physic
effect
water
satur
lung
tissu
find
numer
other
suggest
treatment
target
product
hyaluronan
may
lifesav
present
pandem
benefici
effect
patient
current
ventil
certainli
symptomat
patient
cross
line
respiratori
failur
strongli
suggest
extant
literatur
fortun
evid
exist
readili
avail
eurpean
union
counter
product
call
current
market
author
via
italian
medicin
agenc
aic
might
avail
use
given
weight
find
well
long
track
record
safe
use
particularli
press
need
current
lack
specif
treatment
ard
propos
front
line
especi
itali
spain
consid
immedi
use
compassion
use
guidelin
work
paul
bollyki
md
phd
nadin
nagi
phd
et
al
would
suggest
mg
mouth
three
time
per
day
first
sign
infect
confirm
high
risk
patient
might
reason
initi
dose
find
provid
ration
studi
use
induc
hyaluronan
storm
prospect
doubleblind
clinic
trial
highrisk
patient
strongli
recommend
start
earliest
time
frame
possibl
encourag
reader
recommend
specif
protocol
drug
unanticip
unwant
side
effect
great
caution
must
taken
clinic
applic
compound
certainli
use
direct
supervis
skill
physician
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
conclus
infect
diseas
result
disastr
pandem
enorm
consequ
like
seen
modern
time
propos
induc
hyaluronan
storm
syndrom
ih
model
best
address
heretofor
perplex
respiratori
failur
proxim
caus
death
minor
ever
rise
number
patient
encourag
research
clinician
put
model
test
expand
upon
earli
understand
diseas
addit
treat
prevent
ih
current
infect
individu
aggress
research
effort
undertaken
discov
major
individu
expos
viru
either
minim
asymptomat
minor
highrisk
individu
rapidli
progress
respiratori
failur
death
answer
question
profound
implic
fundament
understand
approach
diseas
individu
institut
charg
manag
futur
threat
global
health
wellb
foundat
shaken
futur
profoundli
shape
histor
event
histori
shape
similar
event
past
let
us
hope
collect
respons
enlighten
cooper
well
reason
futur
direct
includ
report
ih
lung
weight
perform
addit
autopsi
victim
recommend
measur
hyaluron
acid
serum
potenti
indic
ih
statu
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
inhibit
hyaluronan
synthas
elimin
hyaluronan
consid
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
